← Back to Vaccine Database

ChAdOx1 MERS

Viral vector (Non-replicating) vaccine · VDDBV0143

Target & Classification

MERS-CoVMiddle east respiratory syndrome coronavirus
Viral vector (Non-replicating) vaccine
MERS (Middle East Respiratory Syndrome)
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT03399578 Phase 1MERS (Middle East Respiratory Syndrome)
NCT04170829 Phase 1MERS (Middle East Respiratory Syndrome)